Another RAS mutation, NRasQ61K, in melanocytes induced melanoma development with a low incidence rate and only after a long latency; cross-breeding with CDKN2A knockout mice increased the incidence of melanomas, with a reduced latency period [190]. The gene discussed is CDKN2A; the disease is melanoma.